Validating A Cardiovascular Risk Tool For Use In A Contemporary Diabetes Population

Published Aug 12, 2013
Cambridge, UK – Originally derived from a group of diabetes patients recruited from the 1970s to the 1990s, the UKPDS outcomes model is a widely-used risk tool for predicting cardiovascular outcomes, such as heart attack and stroke, in patients with diabetes. As treatment of diabetes and its complications has changed considerably since this time, it may no longer be a useful risk prediction tool. Researchers from the MRC Epidemiology Unit at the University of Cambridge used data from a contemporary cohort of individuals with diabetes detected by screening, the ADDITION-Europe study, to test whether the risk score predicted heart attack and stroke over five years. While the model tended to over-estimate risk, it was good at ranking individuals from low to high risk. As such, it is probably still the most appropriate cardiovascular risk prediction tool to use in individuals with diabetes. Dr. Libo Tao, a researcher on the study, says, “It is reassuring that the UKPDS tool can still be used to rank individuals with diabetes from low to high risk in terms of their chance of having a heart attack or stroke. This means the tool can be used to examine the cost-effectiveness of different approaches to treating diabetes from diagnosis.” The full study, “Performance of the UKPDS Outcomes Model for Prediction of Myocardial Infarction and Stroke in the ADDITION-Europe Trial Cohort,” is published in Value in Health.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision-makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

New Research Reveals Surprising Trends in Women's Health Economics Authorship

May 12, 2025

Value in Health, the official journal of ISPOR announced the publication of new research analyzing women's representation in authorship of papers submitted to and published in Value in Health. The report, “How Well Are Women Represented in Authorship in HEOR? An Analysis of Value in Health: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

Redefining Value in Care for Alzheimer's Disease and Dementia

Apr 8, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that provide crucial insights into the complex health economics of Alzheimer's disease and related dementias (ADRD), offering a roadmap for future research and policy as the aging population grows and novel treatments emerge.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×